Amifampridine Phosphate
Class: Other Miscellaneous Therapeutic Agents
Chemical Name: phosphoric acid;pyridine-3,4-diamine
Molecular Formula: C5H10N3O4P
CAS Number: 446254-47-3
Brands: Firdapse
Introduction
Amifampridine phosphate is a broad spectrum potassium channel blocker.
Uses for Amifampridine Phosphate
Amifampridine phosphate has the following uses:
Amifampridine phosphate is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
Amifampridine Phosphate Dosage and Administration
General
Amifampridine phosphate is available in the following dosage form(s) and strength(s):
Tablets: 10 mg, functionally scored.
Clinicians should be aware that there are 2 different formulations of amifampridine: amifampridine phosphate (Firdapse) and amiframpidine (Ruzurgi). Both are available as scored tablets containing 10 mg of amifampridine and are labeled for use in the treatment of Lambert-Eaton myasthenic syndrome (LEMS). Amifampridine phosphate (Firdapse) is labeled for use in adults, and amiframpidine (Ruzurgi) is labeled for use in pediatric patients 6 to less than 17 years of age.
Dosage
It isessentialthat the manufacturer's labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary:
Adults
Dosage and Administration
The usual recommended starting dosage is 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily).
The recommended starting dosage is 15 mg daily taken orally in 3 divided doses for patients with renal impairment (CLcr 15–90 mL/min), hepatic impairment, and in known N-acetyltransferase 2 (NAT2) poor metabolizers.
Dosage can be increased by 5 mg daily every 3 to 4 days.
Dosage is not to exceed a maximum of 80 mg daily.
The maximum single dose is 20 mg.
Cautions for Amifampridine Phosphate
Contraindications
Amifampridine phosphate is contraindicated in patients with:
A history of seizures.
Hypersensitivity to amifampridine or another aminopyridine.
Warnings/Precautions
Seizures
Amifampridine phosphate can cause seizures. Seizures have been observed in patients without a history of seizures taking amifampridine phosphate at the recommended do...